Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren's syndrome

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
CLINICAL & EXPER RHEUMATOLOGY
Autores
FLORES-CHAVEZ, A.
BRITO-ZERON, P.
NG, W. -f.
SZANTO, A.
RASMUSSEN, A.
PRIORI, R.
BALDINI, C.
ARMAGAN, B.
OEZKIZILTAS, B.
PRAPROTNIK, S.
Citação
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, v.41, n.12, p.2437-2447, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective To analyse how the key components at the time of diagnosis of the Sjogren's phenotype (epidemiological profile, sicca symptoms, and systemic disease) can be influenced by the potential exposure to climate-related natural hazards. Methods For the present study, the following variables were selected for harmonisation and refinement: age, sex, country, fulfilment of 2002/2016 criteria items, dry eyes, dry mouth, and overall ESSDAI score. Climate-related hazards per country were defined according to the OECD and included seven climate-related hazard types: extreme temperature, extreme precipitation, drought, wildfire, wind threats, river flooding, and coastal flooding. Climatic variables were defined as dichotomous variables according to whether each country is ranked among the ten countries with the most significant exposure. Results After applying data-cleaning techniques and excluding people from countries not included in the OECD climate rankings, the database study analysed 16,042 patients from 23 countries. The disease was diagnosed between 1 and 3 years earlier in people living in countries included among the top 10 worst exposed to extreme precipitation, wildfire, wind threats, river flooding, and coastal flooding. A lower frequency of dry eyes was observed in people living in countries exposed to wind threats, river flooding, and coastal flooding, with a level of statistical association being classified as strong (p<0.0001 for the three variables). The frequency of dry mouth was significantly lower in people living in countries exposed to river flooding (p<0.0001) and coastal flooding (p<0.0001). People living in countries included in the worse climate scenarios for extreme temperature (p<0.0001) and river flooding (p<0.0001) showed a higher mean ESSDAI score in comparison with people living in no-risk countries. In contrast, those living in countries exposed to worse climate scenarios for wind threats (p<0.0001) and coastal flooding (p<0.0001) showed a lower mean ESSDAI score in comparison with people living in no-risk countries. Conclusion Local exposure to extreme climate-related hazards plays a role in modulating the presentation of Sjogren across countries concerning the age at which the disease is diagnosed, the frequency of dryness, and the degree of systemic activity.
Palavras-chave
Sjogren's syndrome, dryness, systemic, ESSDAI, climate, epidemiology
Referências
  1. Brito-Zeron P, 2019, CLIN EXP RHEUMATOL, V37, P1052
  2. Brito-Zerón P, 2020, RHEUMATOLOGY, V59, P2350, DOI 10.1093/rheumatology/kez578
  3. Brito-Zerón P, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.47
  4. Carubbi F, 2021, CLIN EXP RHEUMATOL, V39, pS190, DOI 10.55563/clinexprheumatol/5p5x5p
  5. Conrad Nathalie, 2023, Lancet, V401, P1878, DOI 10.1016/S0140-6736(23)00457-9
  6. Duret PM, 2020, ARTHRITIS RES THER, V22, DOI 10.1186/s13075-020-2118-1
  7. Ebi KL, 2021, LANCET, V398, P698, DOI 10.1016/S0140-6736(21)01208-3
  8. Gibert K, 2016, AI COMMUN, V29, P627, DOI 10.3233/AIC-160710
  9. Lee CP, 2019, SCI TOTAL ENVIRON, V657, P1121, DOI 10.1016/j.scitotenv.2018.12.122
  10. Ma KSK, 2023, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.1044462
  11. Machowicz A, 2020, CLIN EXP RHEUMATOL, V38, pS216
  12. MAES MJA, 2022, Monitoring exposure to climate-related hazards, DOI [10.1787/da074cb6-en, DOI 10.1787/DA074CB6-EN]
  13. Mandell JT, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113740
  14. Piovani D, 2023, ENVIRON RES, V224, DOI 10.1016/j.envres.2023.115449
  15. Ramos-Casals M, 2019, LUNG, V197, P427, DOI 10.1007/s00408-019-00243-2
  16. Ramos-Casals M, 2012, BMJ-BRIT MED J, V344, DOI [10.1024/1661-8157/a001133, 10.1136/bmj.e3821]
  17. Rantanen II, 2003, CLIN EXP RHEUMATOL, V21, P682
  18. Retamozo S, 2021, CLIN EXP RHEUMATOL, V39, pS166
  19. ROLANDO M, 1983, ARCH OPHTHALMOL-CHIC, V101, P557
  20. Scott J, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102660
  21. Shapira Y, 2010, NAT REV RHEUMATOL, V6, P468, DOI 10.1038/nrrheum.2010.86
  22. So H, 2022, FRONT MED-LAUSANNE, V9, DOI 10.3389/fmed.2022.837024
  23. Stojan G, 2020, ARTHRITIS RHEUMATOL, V72, P1134, DOI 10.1002/art.41217
  24. Thorlacius GE, 2023, NAT REV RHEUMATOL, V19, P288, DOI 10.1038/s41584-023-00932-6
  25. Touil H, 2023, FRONT IMMUNOL, V14, DOI 10.3389/fimmu.2023.1147447
  26. van Setten G, 2016, ACTA OPHTHALMOL, V94, P499, DOI 10.1111/aos.12985
  27. VITALI C, 1993, ARTHRITIS RHEUM, V36, P340, DOI 10.1002/art.1780360309
  28. Watad A, 2017, J AUTOIMMUN, V82, P13, DOI 10.1016/j.jaut.2017.06.001
  29. Watad A, 2016, EUR J EPIDEMIOL, V31, P1081, DOI 10.1007/s10654-016-0165-3
  30. Working Group I Contribution to the Sixth Assessment Report of the Intergovernmental Panel on Climate Change, 2023, Climate Change 2021-The Physical Science Basis, DOI [10.1017/9781009157896, DOI 10.1017/9781009157896]